Ocular Surface Disease Clinical Trial
Official title:
Outcome of Concomitant Use of Punctal Plugs and Omeg 3 Fatty Acids on Ocular Surface Disease in Patients Using Systemic Isotretinoin
Ocular surface disease is a common adverse effect of systemic isotretinoin therapy.
The investigators consider that punctal plugs and Omega 3 is a good line for treatment of
ocular surface disease associated with systemic isotretinoin therapy
Subjective and objective evaluation of ocular surface disease was done at baseline ,1 and 3 months of the study . ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04067973 -
Impact of Prematurity on the Optic Nerve
|
||
| Completed |
NCT04828057 -
Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting
|
||
| Not yet recruiting |
NCT06375343 -
Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®
|
Phase 1 | |
| Completed |
NCT00346450 -
Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
|
Phase 3 | |
| Completed |
NCT04351100 -
Efficacy of Diacerein on Ocular Surface Disease in Degenerative Arthritis Patients
|
||
| Completed |
NCT03659955 -
Autologous Blood Treatment for Ocular Surface Disease
|
N/A | |
| Completed |
NCT04536129 -
Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure
|
N/A | |
| Completed |
NCT01254370 -
Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
|
Phase 2 | |
| Completed |
NCT00554411 -
Assessing Ocular Surface Changes After Changing Glaucoma Medications
|
N/A | |
| Completed |
NCT03769454 -
A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers
|
Phase 1 | |
| Recruiting |
NCT06256770 -
Evaluation of the Safety and Efficacy of Rigid Breathable Scleral Contact Lenses for the Correction of Ametropia
|
||
| Completed |
NCT04673604 -
From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy
|
N/A | |
| Not yet recruiting |
NCT06370585 -
Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF
|
Phase 1 | |
| Withdrawn |
NCT04735510 -
Novel Use of Restasis and PROSE Devices
|
Phase 3 | |
| Suspended |
NCT00348114 -
Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell Deficiency
|
Phase 2 | |
| Recruiting |
NCT04010422 -
Ocular Function in Autism Spectrum Disorder
|
||
| Completed |
NCT05528016 -
Short and Long-term Results of Skin Versus Skin Plus Orbicularis Resection Blepharoplasty
|
N/A | |
| Completed |
NCT04452279 -
Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification
|
N/A | |
| Completed |
NCT04535388 -
LK Scleral Lens for Patients With Intractable Ocular Surface Diseases
|
N/A | |
| Recruiting |
NCT06298890 -
The Pattern of Dry Eye Disease After Cataract Surgery
|